Study of anti-platelet medicines after TAVR.

What we are studying

Comparing rivaroxaban plus aspirin to clopidogrel plus aspirin after TAVR procedure.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Aortic Stenosis

What is involved

  • 6 on-site visits
  • 2 telephone assessments.

Compensation

None

Contact Information

Study Coordinator
Amanda Morgan
Email
asmorgan@wakehealth.edu
Phone
336-713-4432
Principal Investigator
Dr. Robert Applegate

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.